Agile Thrpe (AGRX)

NASDAQ
0.6415
+0.0070(+1.10%)
After Hours
0.6170
-0.0245(-3.8192%)
- Real-time Data
  • Volume:
    4,095,427
  • Day's Range:
    0.6300 - 0.6700
  • 52 wk Range:
    0.4851 - 50.4000

AGRX Overview

Prev. Close
0.6345
Day's Range
0.63-0.67
Revenue
5.75M
Open
0.6435
52 wk Range
0.4851-50.4
EPS
-26.8
Volume
4,095,427
Market Cap
25.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
10,644,964
P/E Ratio
-
Beta
1.52
1-Year Change
-98.57%
Shares Outstanding
39,026,832
Next Earnings Date
Aug 11, 2022
What is your sentiment on Agile Thrpe?
or
Market is currently closed. Voting is open during market hours.

Agile Thrpe News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Agile Thrpe Analysis

Agile Thrpe Company Profile

Agile Thrpe Company Profile

Employees
30

Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a prescription combined hormonal contraceptive patch, which contains the active ingredients ethinyl estradiol (EE), which is a synthetic estrogen and levonorgestrel (LNG), which is a type of progestin. Twirla delivers 30 micrograms of EE per day, a dose of EE consistent with the dose delivered by many commonly prescribed oral contraceptives. The Company commercializes Twirla in the United States. Twirla leverages the Company’s transdermal patch technology called Skinfusion. Skinfusion is designed to allow drug delivery through the skin while optimizing patch adhesion and patient comfort and wearability.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralNeutralSellStrong Sell
Technical IndicatorsSellStrong SellNeutralStrong BuyStrong Sell
SummaryNeutralSellNeutralNeutralStrong Sell
  • 🤝🏽
    0
    • THIS SHARE WILL FLY
      0
      • AĞZIN BAL YESİN SEKTÖR GÜZEL İŞ YAPAR
        0
    • public offering upcoming get out or stay away
      0
      • yes
        0
        • going up
          0
          • Going up
            0
            • What is the benefit of a reverse split when the stock goes back to below 1 after the split ?
              0
              • Agile Therapeutics Announces 1-For-40 Reverse Stock Split
                0
                • what is going on
                  0
                  • not bad pump lmao
                    0